Pharmacokinetics of clofibrate in familial hypercholesterolemia-Reference-Cited by-同舟云学术

Pharmacokinetics of clofibrate in familial hypercholesterolemia

Published:1977-04 Issue:4 Volume:26 Page:573-582
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Pichardo Rafael,Boulet Lucie,Davignon Jean

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Heterogeneity of familial hyper lipoproteinemia type II on the basis of the fasting plasma triglyceride/cholesterol ration and plasma cholesterol response to chlorophenoxyisobutyrate;Davignon;Rev. Canad. Biol.,1971

2. Fat transport in lipoproteins — An integrated approach to mechanisms and disorders;Fredrickson;New Engl. J. Med.,1967

3. Fat transport in lipoproteins — An integrated approach to mechanisms and disorders;Fredrickson;New Engl. J. Med.,1967

4. Fat transport in lipoproteins — An integrated approach to mechanisms and disorders;Fredrickson;New Engl. J. Med.,1967

5. Fat transport in lipoproteins — An integrated approach to mechanisms and disorders;Fredrickson;New Engl. J. Med.,1967

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low density lipoprotein receptor endocytosis in cardiovascular disease and the factors affecting LDL levels;Progress in Molecular Biology and Translational Science;2023

2. Clofibrate ☆;Reference Module in Biomedical Sciences;2017

3. Hibiscus sabdariffa extract reduces serum cholesterol in men and women;Nutrition Research;2007-03

4. Clofibrate;xPharm: The Comprehensive Pharmacology Reference;2007

5. Methods and Endpoint Issues in Clinical Development of Lipid-Acting Agents with Pleiotropic Effects;The American Journal of Cardiology;1998-04